Valued Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$95.3K Buy
737
+22
+3% +$2.58K 0.03% 74
2026
Q1
$86.6K Buy
715
+271
+61% +$31.3K 0.04% 71
2025
Q4
$47.2K Buy
444
+94
+27% +$8.82K 0.02% 95
2025
Q3
$29.7K Buy
350
+18
+5% +$1.48K 0.01% 120
2025
Q2
$26.5K Sell
332
-38
-10% -$3.02K 0.01% 129
2025
Q1
$33.5K Sell
370
-52
-12% -$4.86K 0.02% 116
2024
Q4
$42.3K Buy
422
+11
+3% +$1.13K 0.03% 98
2024
Q3
$47K Sell
411
-25
-6% -$2.97K 0.03% 83
2024
Q2
$54.2K Buy
436
+210
+93% +$27.1K 0.04% 68
2024
Q1
$30K Sell
226
-181
-44% -$22.3K 0.02% 94
2023
Q4
$42.1K Buy
+407
New +$42.2K 0.04% 56

Other funds holding MRK

Valued Wealth Advisors's MRK Position: Q2 2026 in Review

Valued Wealth Advisors increased its Merck (MRK) stake by 3.1% in Q2 2026, buying an estimated $2.58K and bringing the position to 737 shares worth $95.3K. The position accounts for 0.03% of the portfolio, ranked #74.

Valued Wealth Advisors first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Valued Wealth Advisors held 737 shares of Merck worth $95.3K as of Q2 2026.
  • Valued Wealth Advisors bought 22 Merck shares in Q2 2026, an estimated $2.58K.
  • Merck made up 0.03% of Valued Wealth Advisors's portfolio in Q2 2026, its #74 holding.
  • Valued Wealth Advisors first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Valued Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.